<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hu R</submitter><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><funding>Natural Science Foundation of Shanghai (Natural Science Foundation of Shanghai Municipality)</funding><pagination>322-334</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10923889</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(3)</volume><pubmed_abstract>Pancreatic β-cell failure by WFS1 deficiency is manifested in individuals with wolfram syndrome (WS). The lack of a suitable human model in WS has impeded progress in the development of new treatments. Here, human pluripotent stem cell derived pancreatic islets (SC-islets) harboring WFS1 deficiency and mouse model of β cell specific Wfs1 knockout were applied to model β-cell failure in WS. We charted a high-resolution roadmap with single-cell RNA-seq (scRNA-seq) to investigate pathogenesis for WS β-cell failure, revealing two distinct cellular fates along pseudotime trajectory: maturation and stress branches. WFS1 deficiency disrupted β-cell fate trajectory toward maturation and directed it towards stress trajectory, ultimately leading to β-cell failure. Notably, further investigation of t</pubmed_abstract><journal>Cell death and differentiation</journal><pubmed_title>ISR inhibition reverses pancreatic β-cell failure in Wolfram syndrome models.</pubmed_title><pmcid>PMC10923889</pmcid><funding_grant_id>31970751</funding_grant_id><funding_grant_id>81971078</funding_grant_id><funding_grant_id>32122030</funding_grant_id><funding_grant_id>32370855</funding_grant_id><funding_grant_id>82171166</funding_grant_id><funding_grant_id>21ZR1452400</funding_grant_id><funding_grant_id>32170740</funding_grant_id><pubmed_authors>Xu M</pubmed_authors><pubmed_authors>Shao L</pubmed_authors><pubmed_authors>Le R</pubmed_authors><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Su Q</pubmed_authors><pubmed_authors>Dai P</pubmed_authors><pubmed_authors>Gao Y</pubmed_authors><pubmed_authors>Gong M</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Hu R</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Zhang ZN</pubmed_authors></additional><is_claimable>false</is_claimable><name>ISR inhibition reverses pancreatic β-cell failure in Wolfram syndrome models.</name><description>Pancreatic β-cell failure by WFS1 deficiency is manifested in individuals with wolfram syndrome (WS). The lack of a suitable human model in WS has impeded progress in the development of new treatments. Here, human pluripotent stem cell derived pancreatic islets (SC-islets) harboring WFS1 deficiency and mouse model of β cell specific Wfs1 knockout were applied to model β-cell failure in WS. We charted a high-resolution roadmap with single-cell RNA-seq (scRNA-seq) to investigate pathogenesis for WS β-cell failure, revealing two distinct cellular fates along pseudotime trajectory: maturation and stress branches. WFS1 deficiency disrupted β-cell fate trajectory toward maturation and directed it towards stress trajectory, ultimately leading to β-cell failure. Notably, further investigation of t</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-07-15T11:57:42.108Z</modification><creation>2026-07-04T03:12:03.781Z</creation></dates><accession>S-EPMC10923889</accession><cross_references><pubmed>38321214</pubmed><doi>10.1038/s41418-024-01258-w</doi></cross_references></HashMap>